Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials - Schoenfeld, P; Pimentel, M; Chang, L (Aliment Pharmacol Ther, 2014)
et al.